---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-133657"
form_type: "8-K"
ticker: "CGTX"
cik: "0001455365"
company_name: "COGNITION THERAPEUTICS INC"
filed_at: "2021-11-03T23:59:59+00:00"
generated_at: "2026-06-28T13:51:25.776892+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Cognition Therapeutics appoints Ellen Richstone to board; director Breedlove resigns

## Summary
- Board increased from six to seven directors; Ellen B. Richstone appointed as Class I director effective Nov 1, 2021.
- Richstone will chair the Audit Committee and qualifies as audit committee financial expert under SEC rules.
- Received option to purchase 16,670 shares at $12.10 per share, vesting monthly over 36 months.
- Director Mark H. Breedlove notified resignation effective Dec 31, 2021; decision not due to any disagreement with the company.

## SEC filing metadata
- accession: 0001104659-21-133657
- form_type: 8-K
- ticker: CGTX
- cik: 0001455365
- company_name: COGNITION THERAPEUTICS INC
- filed_at: 2021-11-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1455365/000110465921133657/0001104659-21-133657-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1455365/000110465921133657/tm2131759d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-133657
- JSON: https://secwatch.observer/filing/0001104659-21-133657.json
- Plain text: https://secwatch.observer/filing/0001104659-21-133657.txt

## Key facts
- Executive change
  Mark H. Breedlove resigned as Director at COGNITION THERAPEUTICS INC.
  - Action: resigned
  - Role: Director
  source text: On October 29, 2021, Mark H. Breedlove notified the Board that he intends to resign as a member of the Board, effective December 31, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1455365/000110465921133657/0001104659-21-133657-index.htm
- Executive change
  Ellen B. Richstone was appointed as Class I Director at COGNITION THERAPEUTICS INC.
  - Action: appointed
  - Role: Class I Director
  source text: Effective November 1, 2021, in connection with the Board Increase, the Board appointed Ellen B. Richstone to serve as a Class I member of the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1455365/000110465921133657/0001104659-21-133657-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.